Legend Biotech Corp SEC filings LEGN
Legend Biotech Corp has 386 filings in SEC EDGAR's recent list, going back to Mar 9, 2020. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 144 | Notice of proposed sale | Sep 29, 2026 | — |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 23, 2026 | Sep 21, 2026 |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 3 | Initial insider ownership | Sep 16, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| 3 | Initial insider ownership | Aug 3, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 144 | Notice of proposed sale | Jun 26, 2026 | — |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 144 | Notice of proposed sale | Mar 26, 2026 | — |
| 144 | Notice of proposed sale | Mar 26, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 144 | Notice of proposed sale | Sep 26, 2025 | — |
| 144 | Notice of proposed sale | Sep 24, 2025 | — |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 144 | Notice of proposed sale | Jul 23, 2025 | — |
| 144 | Notice of proposed sale | Jul 23, 2025 | — |
| 144 | Notice of proposed sale | Jun 26, 2025 | — |
| 144 | Notice of proposed sale | Jun 25, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 24, 2025 | — |
| 144 | Notice of proposed sale | Jun 6, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 6, 2025 | — |
| 144 | Notice of proposed sale | May 1, 2025 | — |
| 144 | Notice of proposed sale | Mar 25, 2025 | — |
| 144 | Notice of proposed sale | Mar 25, 2025 | — |
| 144 | Notice of proposed sale | Mar 25, 2025 | — |
| 144 | Notice of proposed sale | Mar 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 144 | Notice of proposed sale | Dec 26, 2024 | — |
| 144 | Notice of proposed sale | Dec 26, 2024 | — |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 144 | Notice of proposed sale | Sep 25, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Sep 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 25, 2024 | — |
| 144 | Notice of proposed sale | Jun 25, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 5, 2024 | — |
| 144 | Notice of proposed sale | Mar 28, 2024 | — |
| 144 | Notice of proposed sale | Mar 27, 2024 | — |
| 144 | Notice of proposed sale | Mar 26, 2024 | — |
| 144 | Notice of proposed sale | Mar 25, 2024 | — |
| 144 | Notice of proposed sale | Mar 25, 2024 | — |
| 144 | Notice of proposed sale | Mar 19, 2024 | — |
| 144/A | Filing | Feb 28, 2024 | — |
| 144 | Notice of proposed sale | Feb 28, 2024 | — |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| 144 | Notice of proposed sale | Feb 23, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 29, 2024 | — |
| 144 | Notice of proposed sale | Dec 27, 2023 | — |
| 144 | Notice of proposed sale | Dec 22, 2023 | — |
| 144 | Notice of proposed sale | Dec 22, 2023 | — |
| 144 | Notice of proposed sale | Dec 12, 2023 | — |
| 144/A | Filing | Oct 17, 2023 | — |
| 144 | Notice of proposed sale | Oct 17, 2023 | — |
| 144 | Notice of proposed sale | Oct 16, 2023 | — |
| 144 | Notice of proposed sale | Sep 27, 2023 | — |
| 144 | Notice of proposed sale | Sep 22, 2023 | — |
| 144 | Notice of proposed sale | Sep 22, 2023 | — |
| 144 | Notice of proposed sale | Sep 18, 2023 | — |
| 144 | Notice of proposed sale | Aug 23, 2023 | — |
| 144 | Notice of proposed sale | Jun 26, 2023 | — |
| 144 | Notice of proposed sale | Jun 22, 2023 | — |
| 144 | Notice of proposed sale | Jun 22, 2023 | — |
| 144 | Notice of proposed sale | Jun 7, 2023 | — |
| 144 | Notice of proposed sale | Jun 6, 2023 | — |
| 144 | Notice of proposed sale | Jun 5, 2023 | — |
| 144 | Notice of proposed sale | Jun 2, 2023 | — |
| 144 | Notice of proposed sale | Jun 1, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 10, 2023 | — |
| 144 | Notice of proposed sale | Apr 21, 2023 | — |
| 144 | Notice of proposed sale | Apr 19, 2023 | — |
| 144 | Notice of proposed sale | Apr 5, 2023 | — |
| 144 | Notice of proposed sale | Apr 5, 2023 | — |
| 144 | Notice of proposed sale | Apr 3, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Jul 12, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
Showing 128 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Somerset, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1801198
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.